Search clinical trials for: zoledronic acid

Total 28074 results

Novartis Pharmaceuticals

Completed

Bisphosphonate Treatment of Osteogenesis Imperfecta

Osteogenesis Imperfecta

United States
Novartis Pharmaceuticals

Completed

Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

Osteogenesis Imperfecta

United States
Novartis Pharmaceuticals
University of Athens

Completed

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Prostate Cancer

Greece
Assiut University

Unknown

Diagnosis of Osteogenesis Imperfecta in Children

Bone Disease, Metabolic

Egypt
University of Alabama at Birmingham
Novartis Pharmaceuticals

Completed

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) (UAB0901)

Mesothelioma

United States
Cttq

Unknown

Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women

Osteoporosis, Postmenopausal
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis

Osteoporosis

United States
Susanne Crocamo

Completed

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Neoplasms | Neoplasms by Site | Breast Cancer | Breast Disease

Brazil
Paolo Caimi, MD
National Cancer Institute (NCI)

Completed

Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute... and other conditions

United States
Novartis Pharmaceuticals

Completed

Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis

Male Osteoporosis

Russian Federation, Argentina, Switzerland, United Kingdom, Germany, Belgium, Czechia, Finland, Spain, Brazil, Romania, Hungary, Denmark, Poland, Norway, Sweden, Austria, South Africa, Slovakia, Australia, Iceland, Italy, Portugal
The Cleveland Clinic
Novartis Pharmaceuticals

Completed

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Osteoporosis

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid

Malignant Neoplasm | Musculoskeletal Complications

United States
Severance Hospital

Completed

Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors

Gastrointestinal Cancer | Bone Metastasis

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years

Postmenopausal Osteoporosis

Turkey
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital; American Society...

Completed

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

Multiple Myeloma

United States
University of Minnesota

Completed

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Ovarian Cancer | Osteoporosis

United States
Novartis Pharmaceuticals

Completed

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Cancer Prostate

Belgium
Novartis Pharmaceuticals

Completed

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Prostate Cancer With Bone Metastasis
Novartis

Completed

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Breast Cancer

Canada
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
Novartis Pharmaceuticals

Completed

Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid (LISA)

Osteoporosis

Australia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)

Paget's Disease of Bone

China
Novartis

Completed

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Neoplasm Metastasis

Hungary
Novartis Pharmaceuticals

Completed

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

Prostate Cancer

United States
Novartis Pharmaceuticals

Completed

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Prostate Cancer

Venezuela
Novartis Pharmaceuticals

Completed

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

Prostate Cancer
Turku University Hospital
Novartis; Academy of Finland; Stryker Nordic

Completed

Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis

Hip Osteoarthritis

Finland
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Breast Cancer | Prostate Cancer | Bone Metastasis

Germany
GlaxoSmithKline
Amgen

Completed

A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Fractures, Bone

Taiwan, Singapore, China
London School of Hygiene and Tropical Medicine
University of Yaounde

Completed

Anti-Malarial Drug Resistance in Cameroon

Malaria
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

Breast Cancer | Osteoporosis
Novartis

Completed

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

Prostate Cancer

Germany
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Neoplasm Metastasis | Renal Cell Cancer

Germany
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Prostate Cancer | Metastatic Cancer

United States
Novartis

Withdrawn

Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee

Osteonecrosis

Australia
Novartis Pharmaceuticals

Completed

Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older

Osteopenia

United States
Hoffmann-La Roche
Roche Pharma AG

Terminated

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma (COMPARE)

Multiple Myeloma

Germany
Mel Shiuann-Sheng Lee
Novartis

Completed

Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy

Functional Outcomes | Prevention of BMD Loss After THR | Serum Markers of Bone Turnover

Taiwan
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Breast Cancer | Osteoporosis

United States
Medical University Innsbruck

Completed

Bisphosphonate Therapy in MONA Spectrum Disorder

Pain | Fracture | Bone Density
Ondokuz Mayıs University

Completed

Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis

Chronic Periodontitis
Institut Cancerologie de l'Ouest

Completed

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma (GEMO)

Prostate Adenocarcinoma

France
Shriners Hospitals for Children
Novartis

Completed

An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta (INFOI)

Osteogenesis Imperfecta

Canada
Dana-Farber Cancer Institute
Novartis; Beth Israel Deaconess Medical Center

Completed

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Breast Cancer

United States
Antonio Lazzari
Massachusetts General Hospital; United States Department of Defense; Spaulding... and other collaborators

Terminated

FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)

Osteoporosis

United States
Chinese PLA General Hospital

Unknown

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

Osteonecrosis
Novartis Pharmaceuticals

Completed

Intra-venous Zoledronic Acid Once Yearly (IVORY)

Post-Menopausal Osteoporosis

Canada
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Cephalon

Terminated

Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

Leukemia

United States
Leiden University Medical Center

Terminated

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) (HR-GCT)

Giant Cell Tumor of Bone | Osteoclastoma

Netherlands, Belgium
Memorial Sloan Kettering Cancer Center

Completed

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Osseous Lesions From Metastatic Breast Cancer

United States

3

Subscribe